6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Expensify and VAT IT Launch Integration Partnership to Simplify Global VAT Reclaim
Just now	United Maritime Reports Improved First Quarter 2026 Financial Results and Declares Quarterly Cash Dividend of $0.10 Per Share
1m ago	Data I/O to Present at the Planet MicroCap Investor Conference Powered by MicroCapClub
1m ago	Rapid7 Q1 2026 Threat Landscape Report Finds Vulnerability Exploitation Overtakes Social Engineering as the Top Initial Access Vector
1m ago	Jamal Satli Iglesias, Marriott International and Aimbridge Hospitality Announce Landmark All-Inclusive Resort in Riviera Maya

About

97.08USD+1.48 +1.55%

Closed • Updated at 13:36 GMT+00:00

Market Cap$19.39B

P/E Ratio13.73

Volume1.07M

Beta0.60

RSI50.53

Gross Margin91.22%

Health TechnologyPharmaceuticals: Major

Incyte Corporation — investor relations, events, news, and company updates on 6ix.

Latest News

Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery

Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease

Community Chat

Ask AI